Find Funding Opportunities

NINDS will no longer participate in both FOAs after 9/27/22 receipt date.

The NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative intends to issue RFA-EB-22-001, BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in summer 2022 with an expected application due date in fall 2022 This FOA will utilize the UG3/UH3 activity code. Details of the planned FOA are provided below.

The National Institute on Drug Abuse (NIDA) intends to solicit proposals from qualified organizations (NAICS Code 541715) having in-house capability to support and provide resources to the participating grantees for completing clinical feasibility studies of novel medical devices in the neurotechnology field. The clinical studies may include both feasibility and larger safety and efficacy assessments in patients affected by the condition being studied. BPMT anticipates running 5 to 15 clinical studies per year over the next 5 years. Most, but not all, are likely to be NIH-defined Clinical Trials https://grants.nih.gov/policy/clinical-trials/definition.htm.

The National Institute on Drug Abuse (NIDA) intends to solicit proposals from qualified organizations (NAICS Code 541715) having in-house capability to support and provide resources to the participating grantees for completing biocompatibility studies, in vivo animal testing compliant with good laboratory (GLP) guidelines, and sterilization and shelf life testing. This contractor will provide support for research protocol development, research staff training, and conduct all testing necessary to support biocompatibility, sterilization, and animal safety studies.

The purpose of this notice is to move the first receipt date to July 15, 2022.

The purpose of this NOSI is to solicit projects on preventive interventions that address cardiometabolic risk factors in populations that experience health disparities.

FAQs for the RFA

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome (DS). This Notice of Special Interest (NOSI) announces NIH support for administrative supplement applications for actively funded projects to meet NIH Down syndrome research objectives related to the NIH INCLUDE Project as listed below.

The purpose of this time-sensitive Request for Information (RFI) is to solicit public input on promising progress and opportunities that have emerged in cerebral palsy (CP) research since the publication of the NINDS/NICHD Strategic Plan for Cerebral Palsy Research in 2017.

This Notice highlights the NINDSs interest in receiving grant applications focused on advancing the careers of a diverse translational research workforce in response to PAR-20-240, NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25).